Retatrutide — lab test, April 2026
COA KVR-2026-F8786B matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
QX43K60Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 30 mg · Lab measured 31.88 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 8 mg using the measured mass, against 7.5 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-F8786B |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 16 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Kovera Labs on April 19, 2026. Reported purity: 99.944%. Net content: 31.88 mg against 30 mg labeled (106% of label). Endotoxins: PASS. Batch #ERX6B. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion